CORONARY ARTERY DISEASE, cilt.22, sa.6, ss.394-400, 2011 (SCI-Expanded)
Background Calcium phosphate deposition is present even in the early phases of the atherosclerotic plaque formation. Calcifying nanoparticles (CNPs), previously known as nanobacteria, have emerged as a potential causative agent for pathological calcification in human vasculature. This study investigates the relationship between the anti-CNPs antibody titers and the extent of coronary calcification.